Virax Biolabs Group (Virax Biolabs Group) Net Margin % : -3,779.22% (As of Sep. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Virax Biolabs Group Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Virax Biolabs Group's Net Income for the six months ended in Sep. 2023 was $-2.91 Mil. Virax Biolabs Group's Revenue for the six months ended in Sep. 2023 was $0.08 Mil. Therefore, Virax Biolabs Group's net margin for the quarter that ended in Sep. 2023 was -3,779.22%.

The historical rank and industry rank for Virax Biolabs Group's Net Margin % or its related term are showing as below:

VRAX' s Net Margin % Range Over the Past 10 Years
Min: -60633.33 Med: -710 Max: -525
Current: -8655

VRAX's Net Margin % is ranked worse than
89.78% of 1027 companies
in the Biotechnology industry
Industry Median: -162.58 vs VRAX: -8655.00

Virax Biolabs Group Net Margin % Historical Data

The historical data trend for Virax Biolabs Group's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virax Biolabs Group Net Margin % Chart

Virax Biolabs Group Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Net Margin %

-710.00

-525.00

-60,633.33

Virax Biolabs Group Semi-Annual Data
	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Net Margin %	Get a 7-Day Free Trial			-	-	-24,066.67	-133,800.00	-3,779.22

Competitive Comparison of Virax Biolabs Group's Net Margin %

For the Biotechnology subindustry, Virax Biolabs Group's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Virax Biolabs Group's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Virax Biolabs Group's Net Margin % distribution charts can be found below:

* The bar in red indicates where Virax Biolabs Group's Net Margin % falls into.

Virax Biolabs Group Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Virax Biolabs Group's Net Margin for the fiscal year that ended in Mar. 2023 is calculated as

Net Margin	=	Net Income (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	-5.457	/	0.009
	=	-60,633.33 %

Virax Biolabs Group's Net Margin for the quarter that ended in Sep. 2023 is calculated as

Net Margin	=	Net Income (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	-2.91	/	0.077
	=	-3,779.22 %

Virax Biolabs Group (NAS:VRAX) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Virax Biolabs Group Net Margin % Related Terms

Thank you for viewing the detailed overview of Virax Biolabs Group's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Virax Biolabs Group (Virax Biolabs Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Virax Biolabs Group Ltd (NAS:VRAX) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

20 North Audley Street, London, GBR, W1K 6LX

Website

https://www.viraxbiolabs.com

Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against major global viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.